Reply
The changes of BCVA were 0.10 ± 0.37 in polypoidal CNV and 0.13 ± 0.18 in idiopathic PCV, with no significant difference between the 2 groups (P = .740). [...]in our study, there were no significant differences between polypoidal CNV and idiopathic PCV in both anti-vascular endothelial growth factor...
Gespeichert in:
Veröffentlicht in: | American journal of ophthalmology 2017-02, Vol.174, p.182 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The changes of BCVA were 0.10 ± 0.37 in polypoidal CNV and 0.13 ± 0.18 in idiopathic PCV, with no significant difference between the 2 groups (P = .740). [...]in our study, there were no significant differences between polypoidal CNV and idiopathic PCV in both anti-vascular endothelial growth factor (VEGF) agents during the 1-year follow-up period. Because fellow eyes covered diseased eyes, some patients could not notice their symptoms and did not know exactly the onset of AMD. |
---|---|
ISSN: | 0002-9394 1879-1891 |
DOI: | 10.1016/j.ajo.2016.11.008 |